Laparoscopic and robotic treatments of visceral artery aneurysms (VAA) are described in the literature12,13,14,15. Still, they historically are limited in daily clinical practice mainly due to limited expertise amongst vascular surgeons and the facility cost of the surgical robots. In addition, endovascular repair continues to represent first-choice management in most cases16. This combination of factors makes evidence concerning the robotic-assisted laparoscopic approach for VAAs limited. Prior to 2010, there were only seven cases of robotically treated VAAs published in the literature. Between 2011 and 2019, a systematic review found only 20 patients and just 27 more between 2020 and 202417. The use of robotic techniques in the treatment of VAAs is increasing at a rapid pace, but the only available data regarding its outcomes remains limited to case reports and case series.
Although other case reports describing similar cases already exist, this study's value lies in its detailed description of the operative technique, including a video presentation-and in its comprehensive protocol for peri-operative patient care.
One of the most important advantages of robotic assisted laparoscopic surgery (RALS) is the extremely low rate of peri-operative complications, thanks to the minimally invasive approach. Many reviews have shown significantly decreased cardiac, respiratory, thromboembolic, and infections compared to open surgery for VAAs. Moreover, the robotic-assisted approach is characterized by early recovery of oral feeding and short hospital stay17. These added benefits might counterbalance the additional cost of the robotic equipment; however, we are unable to provide a detailed cost analysis for this case.
While there are many benefits to the RALS approach, possible disadvantages are the operative time and periods of organ ischemia if performing a vascular reconstruction. There is no information based on large clinical trials concerning the operative time and ischemia times of open surgery of VAAs, but those of RALS may be slightly longer18,19. This may be due to the learning curve and could be liable to improve in the future. However, on review of early data, such longer times did not cause significant adverse clinical outcomes. In our case, the total operative time was 233 min. This is longer than the average reported time in the 2020 review2 (150 ± 87.7 min) but within one standard deviation. The presented case involved complex anatomy with an extra draining artery branch that needed to be controlled and ligated. This was also the first robotic splenic artery surgery in our institution; thus, the relatively longer operative time was needed to instruct assistants in the operating room. We were able to reduce the operative time in the following 3 cases, with the latest one consisting of aneurysm resection and arterial repair (130 min and 188 min for ligation, and 256 min for arterial reconstruction with end-to-end anastomosis).
Early data indicate satisfactory rates of intraoperative conversion to laparoscopic or open surgery (5.6%). Among VAAs, splenic artery aneurysms (SAA) appear particularly susceptible to conversion, primarily due to dense tissue adhesions that complicate vascular control; this was identified as the most frequent reason for procedural failure17. Consequently, patients with hostile abdominal anatomy may carry a higher risk of conversion, emphasizing the importance of careful patient selection to reduce this risk. Patients eligible for RALS should be informed about the possibility of conversion, similar to other minimally invasive procedures such as endovascular or laparoscopic treatments. However, robotic repair offers an advantage over endovascular approaches, as it does not carry the risk of aneurysm reperfusion and rupture, a significant limitation associated with endovascular treatment.
The robotic-assisted laparoscopic splenic artery aneurysm (SAA) resection involves several critical steps to ensure safe and effective aneurysm management. First, pneumoperitoneum is established, and the DaVinci Xi robot is docked to four abdominal ports, with an additional 12 mm assistant port for instrument exchange and a 5 mm port for liver retractor placement. After docking, the greater omentum is dissected from the greater curvature of the stomach, exposing the posterior gastric fat pad and creating access to the lesser sac. The splenic artery is identified along the superior border of the pancreas, and meticulous dissection is performed to isolate the aneurysm and its vascular branches. The inflow and outflow vessels are encircled with vessel loops for vascular control, with the option of using a modified Rumel tourniquet technique for proximal occlusion. Intraoperative FireFly fluorescence imaging is utilized to assess splenic perfusion through the short gastric arteries before proceeding with arterial ligation and aneurysm excision. The aneurysm is resected, the surgical field is irrigated, and hemostasis is secured. Finally, ports are removed under direct visualization, the fascial defects are closed, and the patient is carefully monitored postoperatively for early recovery and return to normal function.
Recommended modifications to the technique are the use of robotic bulldog clamps (Klein Surgical) for vascular control which decreases operating time compared to vessel loop and Rumel tourniquet4. Another modification would be performing an end-to-end anastomosis to reconstruct the splenic artery in patients with questionable collateral blood supply to the spleen, and that would not tolerate splenectomy/splenic embolization.
A future application of this technique would be the expanded use in other visceral artery aneurysms (hepatic, renal, superior mesenteric, and celiac artery aneurysms). Other applications would be performing robotic-assisted arterial bypass and reconstruction procedures, performing hybrid endovascular-robotic techniques, and adopting these skills to perform vascular repairs for iatrogenic injuries when vascular surgeons are consulted intra-operatively.
In conclusion, RALS offers several advantages, although its applicability remains limited to specific situations. Currently, there is neither consensus nor clear evidence to guide optimal patient selection, and defined inclusion and exclusion criteria for RALS candidates are still lacking. In cases of splenic artery aneurysm (SAA), RALS might be preferred over endovascular approaches for aneurysms located at the splenic hilum, particularly when embolization or endograft placement risks sacrificing collateral vessels, potentially leading to splenic infarction or post-embolization syndrome. Additionally, younger patients at higher risk for long-term reintervention after endovascular treatment could also benefit from robotic-assisted procedures.